Literature DB >> 1909711

Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.

R Karttunen1, H M Surcel, G Andersson, H P Ekre, E Herva.   

Abstract

Cell-mediated immunity is essential for protection against the intracellular bacterium Francisella tularensis, which causes tularemia. Positive in vitro T-cell responses in the form of lymphocyte proliferation and lymphokine interleukin 2 (IL-2) and gamma interferon (IFN-gamma) secretion are found in memory immunity. Studies on the secretion of lymphokines with regard to the developing immunity to F. tularensis have not been published. Therefore, 14 subjects with no clinical history of tularemia were vaccinated with a live F. tularensis vaccine strain. The in vitro responses of five subjects (antigen-induced mononuclear cell and whole blood culture DNA synthesis and cytokine secretion) were measured twice a week throughout the period from 0 to 35 days after vaccination, and the peripheral blood lymphocyte subpopulations of nine subjects were determined between days 0 and 14. Positive reactions, i.e., responses exceeding those on day 0, were reached on day 10 with regard to the whole blood culture DNA synthesis response and IL-2 and IFN-gamma secretion and on day 14 with regard to the mononuclear cell DNA synthesis response and tumor necrosis factor alpha (TNF-alpha) secretion. No measurable IL-4 was found in either the immune or nonimmune supernatants. Since the secretion of TNF-alpha was related to immunization, this points to the specificity of the phenomenon, even though the type of secreting cell is not yet known. If it is shown later that specific T cells produce it, the TNF-alpha response and the negative IL-4 finding may speak for the importance of the Th1-like pattern in immunity to F. tularensis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909711      PMCID: PMC269865          DOI: 10.1128/jcm.29.4.753-756.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.

Authors:  R Karttunen; G Andersson; H P Ekre; K Juutinen; H M Surcel; H Syrjälä; E Herva
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

2.  Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.

Authors:  R J Hackett; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

3.  The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.

Authors:  M R Shalaby; T Espevik; G C Rice; A J Ammann; I S Figari; G E Ranges; M A Palladino
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

4.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.

Authors:  P Scheurich; B Thoma; U Ucer; K Pfizenmaier
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

5.  Francisella tularensis-specific T-cell clones are human leukocyte antigen class II restricted, secrete interleukin-2 and gamma interferon, and induce immunoglobulin production.

Authors:  H M Surcel; J Ilonen; K Poikonen; E Herva
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

7.  Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.

Authors:  S Heidenreich; M Weyers; J H Gong; H Sprenger; M Nain; D Gemsa
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

8.  Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells.

Authors:  N E Street; J H Schumacher; T A Fong; H Bass; D F Fiorentino; J A Leverah; T R Mosmann
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

9.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes.

Authors:  M C Cuturi; M Murphy; M P Costa-Giomi; R Weinmann; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  11 in total

1.  Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.

Authors:  H M Surcel; H Syrjälä; R Karttunen; S Tapaninaho; E Herva
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Levels of interleukin 6 and tumor necrosis factor in serum from humans vaccinated with live, attenuated Francisella tularensis.

Authors:  T Krakauer
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

Review 3.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

4.  Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.

Authors:  Claudette L Fuller; Katherine C Brittingham; Mark W Porter; Matthew J Hepburn; Patricia L Petitt; Phillip R Pittman; Sina Bavari
Journal:  Mol Immunol       Date:  2007-03-08       Impact factor: 4.407

5.  Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain.

Authors:  Meenakshi Malik; Chandra Shekhar Bakshi; Maha Alqahtani; Zhuo Ma; Kayla Fantone
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

6.  Immunity to Francisella.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  Front Microbiol       Date:  2011-02-16       Impact factor: 5.640

7.  Development of functional and molecular correlates of vaccine-induced protection for a model intracellular pathogen, F. tularensis LVS.

Authors:  Roberto De Pascalis; Alicia Y Chou; Catharine M Bosio; Chiung-Yu Huang; Dean A Follmann; Karen L Elkins
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

8.  Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.

Authors:  Kjell Eneslätt; Igor Golovliov; Patrik Rydén; Anders Sjöstedt
Journal:  Front Cell Infect Microbiol       Date:  2018-02-07       Impact factor: 5.293

Review 9.  Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

Authors:  Lydia M Roberts; Daniel A Powell; Jeffrey A Frelinger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-06       Impact factor: 5.293

10.  Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate.

Authors:  Eun-Ju Kim; Sang-Hee Park; Young-Sill Choi; Soo-Kyoung Shim; Mi-Yeoun Park; Man Suck Park; Kyu-Jam Hwang
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.